Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Microfluidics for Circulating Biomarkers Summit 2019

Lydia Sohn's Biography



Lydia Sohn, Almy C. Maynard and Agnes Offield Maynard Chair in Mechanical Engineering, University of California-Berkeley

Lydia L. Sohn received her A.B. (Chemistry and Physics, 1988), M.S. (Physics, 1990), and Ph.D. (Physics, 1992) from Harvard University. She was an NSF/NATO postdoc at Delft University of Technology and a postdoc at AT&T Bell Laboratories (1993-1995). Sohn was an Assistant Professor of Physics at Princeton University prior to joining the Mechanical Engineering Dept. at UC Berkeley in 20013. Her work focuses on developing quantitative techniques to probe single cells. Sohn has received numerous awards including the NSF CAREER, Army of Research Young Investigator Award, DuPont Young Professor Award, and a Bakar Fellowship. In 2014, she was one of five winners in the “Identifying Platform Technologies for Advancing Life Sciences Research” competition for her work on Node-Pore Sensing. Most recently, she was elected a Fellow of the American Institute for Medical and Biological Engineering.

Lydia Sohn Image

Screening for Tumor-Derived Exosomes for Early Detection of Lung Cancer

Thursday, 10 October 2019 at 09:45

Add to Calendar ▼2019-10-10 09:45:002019-10-10 10:45:00Europe/LondonScreening for Tumor-Derived Exosomes for Early Detection of Lung CancerMicrofluidics for Circulating Biomarkers Summit 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Late-stage diagnosis is the major contributor to the poor survival of lung cancer patients: 57% of patients diagnosed with lung cancer have metastatic disease and an abysmal 5-year survival rate of 5.7%.  The lack of symptoms specific to early-stage lung cancer and the low sensitivity and high cost of current screening methods (e.g. computed tomography) are current barriers to early diagnosis.  To address this challenge and enable lung-cancer screening, we are developing a sensitive, simple-to-use, and readily accessible platform to screen for lung tumor-derived extracellular vesicles (EVs) in saliva.  In this talk, I will discuss our platform, which is based on “Node-Pore Sensing” (NPS), and our work up to date in this challenging goal.


Add to Calendar ▼2019-10-10 00:00:002019-10-10 00:00:00Europe/LondonMicrofluidics for Circulating Biomarkers Summit 2019Microfluidics for Circulating Biomarkers Summit 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com